Home688319 • SHA
add
Chengdu Olymvax Biopharmaceuticals Inc
Previous close
¥30.38
Day range
¥29.43 - ¥30.74
Year range
¥12.45 - ¥34.68
Market cap
12.33B CNY
Avg Volume
9.00M
P/E ratio
190.91
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 197.24M | -2.46% |
Operating expense | 172.26M | 0.17% |
Net income | -25.22M | -250.73% |
Net profit margin | -12.79 | -254.66% |
Earnings per share | — | — |
EBITDA | 19.07M | -31.62% |
Effective tax rate | -5.84% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 249.21M | 3.12% |
Total assets | 2.02B | 11.95% |
Total liabilities | 1.12B | 28.11% |
Total equity | 903.98M | — |
Shares outstanding | 405.71M | — |
Price to book | 13.62 | — |
Return on assets | 1.31% | — |
Return on capital | 1.92% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -25.22M | -250.73% |
Cash from operations | 72.45M | 39.33% |
Cash from investing | -25.01M | -51,451.12% |
Cash from financing | 14.45M | 171.95% |
Net change in cash | 61.89M | 94.25% |
Free cash flow | 119.38M | 111.97% |
About
Founded
Dec 11, 2009
Website
Employees
463
